Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference

Rhea-AI Summary

Bristol Myers Squibb (NYSE: BMY) will participate in a fireside chat at the Guggenheim Healthcare Talks 2023 Oncology Conference on February 9, 2023, at 1:00 p.m. ET. Chris Boerner, Ph.D., Executive Vice President and Chief Commercialization Officer, will address inquiries about the company. The event will be live-streamed, with an archived version available later that day. Bristol Myers Squibb is dedicated to discovering and delivering innovative medicines to help patients combat serious diseases.

NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at the Guggenheim Healthcare Talks 2023 Oncology Conference on Thursday, February 9, 2023. Chris Boerner, Ph.D., Executive Vice President, Chief Commercialization Officer, will answer questions about the company at 1:00 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20230203005046/en/

Bristol Myers Squibb

Media:

media@bms.com

Investor Relations:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

What event will Bristol Myers Squibb (BMY) participate in on February 9, 2023?

Bristol Myers Squibb will take part in a fireside chat at the Guggenheim Healthcare Talks 2023 Oncology Conference.

Who will represent Bristol Myers Squibb at the Guggenheim Healthcare Conference?

Chris Boerner, Ph.D., Executive Vice President and Chief Commercialization Officer, will represent Bristol Myers Squibb.

What time is Bristol Myers Squibb's talk at the Oncology Conference?

The fireside chat will take place at 1:00 p.m. ET.

Where can I watch the Bristol Myers Squibb (BMY) conference talk?

Investors and the public can listen via a live webcast on http://investor.bms.com.

Will there be an archive of the Bristol Myers Squibb conference talk?

Yes, an archived edition of the session will be available later on the same day.